Should We Use Dialyzable β-Blockers in Hemodialysis?
Kidney Med
.
2022 Apr 20;4(5):100468.
doi: 10.1016/j.xkme.2022.100468.
eCollection 2022 May.
Authors
Panagiotis I Georgianos
1
,
Theodoros Eleftheriadis
2
,
Vassilios Liakopoulos
1
Affiliations
1
Section of Nephrology and Hypertension, First Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
2
Department of Nephrology, Faculty of Medical Sciences, University of Thessaly, Larissa, Greece.
PMID:
35539429
PMCID:
PMC9079235
DOI:
10.1016/j.xkme.2022.100468
No abstract available
Publication types
Editorial